U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06932354) titled 'Metabolic Monitoring During Therapeutic Hypothermia (Cooling) for Hypoxic Ischaemic Encephalopathy' on Jan. 26, 2021.
Brief Summary: This study aims to determine if CGM can be safely used in these babies, and to use this alongside innovative methods to measure alternative fuels to optimise care of these vulnerable babies.
Study Start Date: May 10, 2019
Study Type: INTERVENTIONAL
Condition:
Hypoxic-Ischemic Encephalopathy
Intervention:
DEVICE: CGM
masked continuous glucose monitoring
Recruitment Status: COMPLETED
Sponsor: Kathryn Beardsall
Information provided by (Responsible Party): Kathryn Beardsall, Cambridge University...